Aequus Pharmaceu Stock Price, News & Analysis

AQSZF OTC

Company Description

Aequus Pharmaceuticals Inc. (AQSZF) is a specialty pharmaceutical company focused on developing and commercializing high-quality products. Founded in 2015, the company has grown multiple products in therapeutic areas like Ophthalmology, Optometry, Transplant, and Rare Disease. Aequus plans to expand its Canadian commercial platform through sales, marketing, and strategic partnerships.

The company's Evolve® range of products is currently on hold in Canada due to a switch in MDSAP provider by Medicom Healthcare (UK). Once the certification process is complete, sales will resume, reaffirming Aequus' commitment to delivering innovative solutions.

With a dedication to patient well-being and a focus on enhancing the Canadian marketplace, Aequus Pharmaceuticals is poised for continued growth and success.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

- %

Performance 1 year

$517.3K

Market Cap

132.6M

Shares outstanding

Latest News

View All

August 30, 2023

9.91%

Aequus Reports Second Quarter 2023 Financial Highlights and General Update

earnings

August 24, 2023

0.00%

SEC Filings

View All

No SEC filings available for Aequus Pharmaceu.

Financial Highlights

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Aequus Pharmaceu (AQSZF)?

The current stock price of Aequus Pharmaceu (AQSZF) is $0.003 as of April 25, 2025.

What is the market cap of Aequus Pharmaceu (AQSZF)?

The market cap of Aequus Pharmaceu (AQSZF) is approximately 517.3K.

What is Aequus Pharmaceuticals Inc. focused on?

Aequus specializes in developing and commercializing high-quality pharmaceutical products.

When will sales of Evolve® products resume in Canada?

Sales will resume once MDSAP Certification is issued.

What is Aequus' commitment to patients in Canada?

The company remains dedicated to delivering innovative solutions that enhance patient well-being.

When was Aequus Pharmaceuticals founded?

Aequus was founded in 2015.

In which therapeutic areas has Aequus grown products?

The company has grown products in Ophthalmology, Optometry, Transplant, and Rare Disease.

How does Aequus plan to expand its Canadian platform?

Aequus plans to expand through sales, marketing, and partnerships.

Why are Evolve® products currently on hold in Canada?

The pause is due to a switch in MDSAP provider by Medicom Healthcare (UK).

What sets Aequus Pharmaceuticals apart in the market?

The company's focus on high-quality, differentiated products and commitment to patient care.

Where can I find more information about Aequus Pharmaceuticals?

Visit the company's website at www.aequuspharma.ca for further details.

What is Aequus Pharmaceuticals' stock symbol?

AQSZF on the OTCQB.